홈 > 시장보고서 > 의약품 > 백신

시장보고서

상품코드

1597054

아시아태평양의 가금용 백신 시장 예측(-2031년)

Asia Pacific Poultry Vaccines Market Forecast to 2031 - Regional Analysis - by Type, Technology, Dosage Form, Disease, Route Of Administration, and End User

발행일: 2024년 10월 | 리서치사:

The Insight Partners | 페이지 정보: 영문 136 Pages | 배송안내 : 즉시배송

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

아시아태평양 가금류 백신 시장은 2023년 7억 5,266만 달러로 평가되었고, 2031년에는 15억 1,433만 달러에 이를 것으로 예측되며, 2023년부터 2031년까지의 CAGR은 9.1%를 기록할 것으로 추정됩니다.

대량 백신 접종에 대한 정부의 지원과 혁신적인 계획이 아시아태평양 가금류 백신 시장을 뒷받침하고 있습니다.

세계 질병 부담(GBD)이 증가함에 따라 세계 각국의 정부는 가금용 백신 접종에 대한 지원을 하고 있습니다. 몇 가지 예방 접종 프로그램이 포함됩니다.

2022년 12월, 인도 정부는 '가축 위생·질병 관리 체계'와 같은 계획의 시작을 발표했습니다. 또, 이 제도는 「조사 및 기술 혁신, 홍보 및 계발, 연수 관련 활동」을 대상으로 하고 있으며, 100% 중앙이 자금을 거출하고 있습니다.

따라서 이러한 정부지원에 의한 집단예방접종의 추진과 혁신적인 제도의 설계는 향후 몇 년간의 가금시장의 성장에 유리한 기회를 제공할 것으로 예상됩니다.

아시아태평양 가금류 백신 시장 개요

아시아태평양 가금류 백신 시장은 중국, 일본, 인도, 호주, 한국 및 기타 아시아태평양 국가로 구분됩니다. 기업의 존재, 다양한 정부 기관 과 동물 협회에 의한 대처 등의 요인에 의해 크게 성장할 것으로 기대되고 있습니다.

아시아태평양 가금류 백신 시장의 수익과 2031년까지의 예측(단위: 100만 달러)

아시아태평양 가금류 백신 시장 세분화

아시아태평양 가금류 백신 시장은 유형별, 기술별, 투여형별, 질환별, 투여경로별, 최종사용자별, 국가별로 분류됩니다.

유형별로 아시아태평양 가금류 백신 시장은 육계와 레이어로 2분화됩니다.

기술 측면에서 아시아태평양의 가금류 백신 시장은 약독생 백신, 불활화 백신, 재조합 백신으로 분류됩니다.

제형별로, 아시아태평양의 가금류 백신 시장은 액체 백신, 동결건조 백신, 분말/분체 백신으로 구분됩니다. 2023년에는 액체 백신이 최대 시장 점유율을 차지했습니다.

질병별로 아시아태평양의 가금류 백신 시장은 조류 인플루엔자, 전염성 기관지염, 말렉병, 조류 살모넬라증, 전염성 활액포염(IBD), 뉴캐슬병 등으로 분류됩니다. 2023년에 조류독감이 가장 큰 시장 점유율을 차지했습니다.

투여 경로별로 아시아태평양 가금류 백신 시장은 식수(D/W), 근육내 투여(I/M), 피하 투여(I/S) 등으로 구분됩니다. 식수(D/W) 부문은 2023년에 가장 큰 시장 점유율을 차지했습니다.

최종 사용자별로는 아시아태평양의 가금용 백신 시장은 양계장, 부화장, 동물병원, 가금용 백신접종센터, 클리닉으로 구분됩니다. 양계장 부화장 부문이 2023년에 가장 큰 시장 점유율을 차지했습니다.

국가별로 아시아태평양 가금류 백신 시장은 중국, 인도, 일본, 호주, 한국 및 기타 아시아태평양 국가로 구분됩니다. 2023년에는 중국이 아시아태평양 가금류 백신 시장 점유율을 독점했습니다.

Boehringer Ingelheim International GmbH, Zoetis Inc, Phybro Animal Health Corp, Hester Biosciences Ltd, Venky's(India) Ltd, Dechra Pharmaceuticals PLC, Elanco Animal Health Inc, Merck KGaA, Ceva, Nisseiken Co Ltd, Vaccinova AB.는 아시아태평양용 백신 시장에서 사업을 전개하는 주요 기업입니다.

시장 성장 촉진요인
- 가금질환의 유병률 상승
- 가금산업의 성장
시장 성장 억제요인
- 예방접종 실패와 부적절한 취급
시장 기회
- 대량 백신접종에 대한 정부의 지원과 혁신적인 체계
향후의 동향
- 벡터 백신 및 혼합 백신의 진보
성장 촉진요인과 억제요인의 영향

제5장 아시아태평양 가금용 백신 시장 분석

가금용 백신 시장 수익(2021-2031년)

제6장 아시아태평양 가금용 백신 시장 분석 : 유형별

육계(육용 닭)
레이어(계란용 닭)

제7장 아시아태평양의 가금용 백신 시장 분석 : 기술별

생백신
불활성화 백신
재조합 백신

제8장 아시아태평양의 가금용 백신 시장 분석 : 제형별

액체 백신
프리즈 드라이 백신
분말 백신

제9장 아시아태평양의 가금용 백신 시장 분석 : 질환별

조류 인플루엔자
조류 살모넬라증
말렉병
감염성 기관지염(IB)
감염성 활액포염(IBD)
뉴캐슬병
기타

제10장 아시아태평양의 가금용 백신 시장 분석 : 투여경로별

식수(D/W)
근육내 투여(I/M)
피하 투여(S/C)
기타

제11장 아시아태평양의 가금용 백신 시장 분석 : 최종 사용자별

양계장
동물병원
가금용 백신 접종 센터, 진료소

제12장 아시아태평양의 가금용 백신 시장 : 국가별 분석

아시아태평양 시장 개요
- 중국
- 인도
- 일본
- 호주
- 한국
- 기타 아시아태평양 국가

제13장 업계 정세

가금용 백신 시장에서의 성장 전략
유기적 전개
무기적 전개

제14장 기업 프로파일

Boehringer Ingelheim International GmbH
Zoetis Inc
Phibro Animal Health Corp
Hester Biosciences Ltd
Venky's(India) Ltd
Dechra Pharmaceuticals PLC
Elanco Animal Health Inc
Merck KGaA
Ceva
Nisseiken Co Ltd
Vaccinova AB

제15장 부록

JHS 24.12.04

The Asia Pacific poultry vaccines market was valued at US$ 752.66 million in 2023 and is expected to reach US$ 1,514.33 million by 2031; it is estimated to record a CAGR of 9.1% from 2023 to 2031.

Government Support for Mass Vaccination Drives and Innovative Schemes Boost Asia Pacific Poultry Vaccines Market

Government worldwide is supportive against poultry vaccination with rising Global Burden of Disease (GBD). The support involves launching of mass vaccination schemes and several vaccination programs at vaccination centers or through door-step immunization services.

In December 2022, the Indian Government announced launching of schemes such as the "Livestock Health & Disease Control Scheme" improve the animal health sector by implementing prophylactic vaccination programs against several diseases. This scheme is Central or State-driven and funded with a sharing pattern of 60:40. Also, the scheme covers "research & innovation, publicity & awareness, training & allied activities" that are 100% Center-funded.

Therefore, such government support for mass vaccination drives and designing innovative schemes is anticipated to provide lucrative opportunities for the poultry market growth in the coming years.

Asia Pacific Poultry Vaccines Market Overview

The Asia Pacific poultry vaccines market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. The market in Asia Pacific is expected to grow considerably owing to factors such as the increasing incidences of livestock diseases, the rising incidences of zoonotic diseases, the presence of leading players, and initiatives taken by various government agencies and animal associations. Further, developing healthcare infrastructure and increasing per capita animal healthcare expenditure are projected to drive the Asia Pacific poultry vaccines market during the forecast period.

Asia Pacific Poultry Vaccines Market Revenue and Forecast to 2031 (US$ Million)

Asia Pacific Poultry Vaccines Market Segmentation

The Asia Pacific poultry vaccines market is categorized into type, technology, dosage form, disease, route of administration, end user, and country.

Based on type, the Asia Pacific poultry vaccines market is bifurcated into broiler and layer. The broiler segment held a larger market share in 2023.

In terms of technology, the Asia Pacific poultry vaccines market is categorized into live attenuated vaccines, inactivated vaccines, and recombinant vaccines. The live attenuated vaccines segment held the largest market share in 2023.

By dosage form, the Asia Pacific poultry vaccines market is segmented into liquid vaccines, freeze-dried vaccines, and dust/powdered form vaccines. The liquid vaccines segment held the largest market share in 2023.

Based on disease, the Asia Pacific poultry vaccines market is categorized into avian influenza, infectious bronchitis, Marek's disease, avian salmonellosis, infectious bursal disease (IBD), Newcastle disease, and others. The avian influenza segment held the largest market share in 2023.

In terms of route of administration, the Asia Pacific poultry vaccines market is segmented into drinking water (D/W), intramuscular (I/M), subcutaneous (I/S), and others. The drinking water (D/W) segment held the largest market share in 2023.

Based on end user, the Asia Pacific poultry vaccines market is segmented into poultry farms & hatchery, veterinary hospitals, and poultry vaccination enters & clinics. The poultry farms & hatchery segment held the largest market share in 2023.

By country, the Asia Pacific poultry vaccines market is segmented into China, India, Japan, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific poultry vaccines market share in 2023.

Boehringer Ingelheim International GmbH, Zoetis Inc, Phibro Animal Health Corp, Hester Biosciences Ltd, Venky's (India) Ltd, Dechra Pharmaceuticals PLC, Elanco Animal Health Inc, Merck KGaA, Ceva, Nisseiken Co Ltd, and Vaccinova AB. are some of the leading companies operating in the Asia Pacific poultry vaccines market.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

4. Asia Pacific Poultry Vaccines Market - Key Market Dynamics

4.1 Market Drivers
- 4.1.1 Rising Prevalence of Poultry Diseases
- 4.1.2 Growing Poultry Industry
4.2 Market Restraints
- 4.2.1 Vaccination Failure and Improper Handling
4.3 Market Opportunities
- 4.3.1 Government Support for Mass Vaccination Drives and Innovative Schemes
4.4 Future Trends
- 4.4.1 Advancements in Vectored and Combination Vaccines
4.5 Impact of Drivers and Restraints:

5. Asia Pacific Poultry Vaccines Market Analysis

5.1 Poultry Vaccines Market Revenue (US$ Million), 2021-2031

6. Asia Pacific Poultry Vaccines Market Analysis - by Type

6.1 Overview
6.2 Broiler
- 6.2.1 Overview
- 6.2.2 Broiler: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
6.3 Layer
- 6.3.1 Overview
- 6.3.2 Layer: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)

7. Asia Pacific Poultry Vaccines Market Analysis - by Technology

7.1 Overview
7.2 Live Attenuated Vaccines
- 7.2.1 Overview
- 7.2.2 Live Attenuated Vaccines: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
7.3 Inactivated Vaccines
- 7.3.1 Overview
- 7.3.2 Inactivated Vaccines: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
7.4 Recombinant Vaccines
- 7.4.1 Overview
- 7.4.2 Recombinant Vaccines: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)

8. Asia Pacific Poultry Vaccines Market Analysis - by Dosage Form

8.1 Overview
8.2 Liquid Vaccines
- 8.2.1 Overview
- 8.2.2 Liquid Vaccines: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
8.3 Freeze-Dried Vaccines
- 8.3.1 Overview
- 8.3.2 Freeze-Dried Vaccines: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
8.4 Dust/Powdered Vaccines
- 8.4.1 Overview
- 8.4.2 Dust/Powdered Vaccines: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)

9. Asia Pacific Poultry Vaccines Market Analysis - by Disease

9.1 Overview
9.2 Avian Influenza
- 9.2.1 Overview
- 9.2.2 Avian Influenza: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
9.3 Avian Salmonellosis
- 9.3.1 Overview
- 9.3.2 Avian Salmonellosis: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
9.4 Marek's Disease
- 9.4.1 Overview
- 9.4.2 Marek's Disease: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
9.5 Infectious Bronchitis (IB)
- 9.5.1 Overview
- 9.5.2 Infectious Bronchitis (IB): Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
9.6 Infectious Bursal Disease (IBD)
- 9.6.1 Overview
- 9.6.2 Infectious Bursal Disease (IBD): Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
9.7 Newcastle Disease
- 9.7.1 Overview
- 9.7.2 Newcastle Disease: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
9.8 Others
- 9.8.1 Overview
- 9.8.2 Others: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)

10. Asia Pacific Poultry Vaccines Market Analysis - by Route of Administration

10.1 Overview
10.2 Drinking Water (D/W)
- 10.2.1 Overview
- 10.2.2 Drinking Water (D/W): Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
10.3 Intramuscular (I/M)
- 10.3.1 Overview
- 10.3.2 Intramuscular (I/M): Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
10.4 Subcutaneous (S/C)
- 10.4.1 Overview
- 10.4.2 Subcutaneous (S/C): Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
10.5 Others
- 10.5.1 Overview
- 10.5.2 Others: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)

11. Asia Pacific Poultry Vaccines Market Analysis - by End User

11.1 Overview
11.2 Poultry Farms
- 11.2.1 Overview
- 11.2.2 Poultry Farms: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
11.3 Veterinary Hospitals
- 11.3.1 Overview
- 11.3.2 Veterinary Hospitals: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
11.4 Poultry Vaccination Centers & Clinics
- 11.4.1 Overview
- 11.4.2 Poultry Vaccination Centers & Clinics: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)

12. Asia Pacific Poultry Vaccines Market - Country Analysis

12.1 Asia Pacific Market Overview
- 12.1.1 Poultry Vaccines Market Breakdown by Countries
  - 12.1.1.1 China: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.1.1.1.1 Overview
    - 12.1.1.1.2 China: Poultry Vaccines Market Breakdown by Type
    - 12.1.1.1.3 China: Poultry Vaccines Market Breakdown by Technology
    - 12.1.1.1.4 China: Poultry Vaccines Market Breakdown by Dosage Form
    - 12.1.1.1.5 China: Poultry Vaccines Market Breakdown by Disease
    - 12.1.1.1.6 China: Poultry Vaccines Market Breakdown by Route of Administration
    - 12.1.1.1.7 China: Poultry Vaccines Market Breakdown by End User
  - 12.1.1.2 India: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.1.1.2.1 Overview
    - 12.1.1.2.2 India: Poultry Vaccines Market Breakdown by Type
    - 12.1.1.2.3 India: Poultry Vaccines Market Breakdown by Technology
    - 12.1.1.2.4 India: Poultry Vaccines Market Breakdown by Dosage Form
    - 12.1.1.2.5 India: Poultry Vaccines Market Breakdown by Disease
    - 12.1.1.2.6 India: Poultry Vaccines Market Breakdown by Route of Administration
    - 12.1.1.2.7 India: Poultry Vaccines Market Breakdown by End User
  - 12.1.1.3 Japan: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.1.1.3.1 Overview
    - 12.1.1.3.2 Japan: Poultry Vaccines Market Breakdown by Type
    - 12.1.1.3.3 Japan: Poultry Vaccines Market Breakdown by Technology
    - 12.1.1.3.4 Japan: Poultry Vaccines Market Breakdown by Dosage Form
    - 12.1.1.3.5 Japan: Poultry Vaccines Market Breakdown by Disease
    - 12.1.1.3.6 Japan: Poultry Vaccines Market Breakdown by Route of Administration
    - 12.1.1.3.7 Japan: Poultry Vaccines Market Breakdown by End User
  - 12.1.1.4 Australia: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.1.1.4.1 Overview
    - 12.1.1.4.2 Australia: Poultry Vaccines Market Breakdown by Type
    - 12.1.1.4.3 Australia: Poultry Vaccines Market Breakdown by Technology
    - 12.1.1.4.4 Australia: Poultry Vaccines Market Breakdown by Dosage Form
    - 12.1.1.4.5 Australia: Poultry Vaccines Market Breakdown by Disease
    - 12.1.1.4.6 Australia: Poultry Vaccines Market Breakdown by Route of Administration
    - 12.1.1.4.7 Australia: Poultry Vaccines Market Breakdown by End User
  - 12.1.1.5 South Korea: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.1.1.5.1 Overview
    - 12.1.1.5.2 South Korea: Poultry Vaccines Market Breakdown by Type
    - 12.1.1.5.3 South Korea: Poultry Vaccines Market Breakdown by Technology
    - 12.1.1.5.4 South Korea: Poultry Vaccines Market Breakdown by Dosage Form
    - 12.1.1.5.5 South Korea: Poultry Vaccines Market Breakdown by Disease
    - 12.1.1.5.6 South Korea: Poultry Vaccines Market Breakdown by Route of Administration
    - 12.1.1.5.7 South Korea: Poultry Vaccines Market Breakdown by End User
  - 12.1.1.6 Rest of APAC: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.1.1.6.1 Overview
    - 12.1.1.6.2 Rest of APAC: Poultry Vaccines Market Breakdown by Type
    - 12.1.1.6.3 Rest of APAC: Poultry Vaccines Market Breakdown by Technology
    - 12.1.1.6.4 Rest of APAC: Poultry Vaccines Market Breakdown by Dosage Form
    - 12.1.1.6.5 Rest of APAC: Poultry Vaccines Market Breakdown by Disease
    - 12.1.1.6.6 Rest of APAC: Poultry Vaccines Market Breakdown by Route of Administration
    - 12.1.1.6.7 Rest of APAC: Poultry Vaccines Market Breakdown by End User

13. Industry Landscape

13.1 Overview
13.2 Growth Strategies in the Poultry Vaccines Market
13.3 Organic Developments
- 13.3.1 Overview
13.1 Inorganic Developments
- 13.1.1 Overview

14. Company Profiles

14.1 Boehringer Ingelheim International GmbH
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 Zoetis Inc
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 Phibro Animal Health Corp
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 Hester Biosciences Ltd
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 Venky's (India) Ltd
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 Dechra Pharmaceuticals PLC
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
14.7 Elanco Animal Health Inc
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
14.8 Merck KGaA
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments
14.9 Ceva
- 14.9.1 Key Facts
- 14.9.2 Business Description
- 14.9.3 Products and Services
- 14.9.4 Financial Overview
- 14.9.5 SWOT Analysis
- 14.9.6 Key Developments
14.10 Nisseiken Co Ltd
- 14.10.1 Key Facts
- 14.10.2 Business Description
- 14.10.3 Products and Services
- 14.10.4 Financial Overview
- 14.10.5 SWOT Analysis
- 14.10.6 Key Developments
14.11 Vaccinova AB
- 14.11.1 Key Facts
- 14.11.2 Business Description
- 14.11.3 Products and Services
- 14.11.4 Financial Overview
- 14.11.5 SWOT Analysis
- 14.11.6 Key Developments

15. Appendix

15.1 About The Insight Partners
15.2 Glossary of Terms

02-2025-2992
(주말 및 공휴일 제외)

라이선스 / 가격

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다.

US $ 3,450

￦ 4,794,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 4,450

￦ 6,184,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 5,450

￦ 7,574,000

※ 부가세 별도